Prof. GÜL BAKTIR

Publication Network

Articles 44

1. "Sihir" den "Tedavi" ye Mantarlar

Baktır G.

İYYU Journal of Phytopharmacy , vol.1, no.1, pp.1-8, 2025 (Peer-Reviewed Journal)

2. Adiponectin: ‘a metabolic ballcock’ modulating immune responses and male reproduction

Dutta S., Sengupta P., Chakravarthi S., İREZ T., BAKTIR G.

Chemical Biology Letters , vol.8, no.4, pp.171-182, 2021 (Scopus)

3. Serum vitamin D levels in healthy urban population at reproductive age: Effects of age, gender and season

KARACAN M., Usta A., BİÇER S., BAKTIR G., Gündogan G. İ., Usta C. S., et al.

Central European Journal of Public Health , vol.28, no.4, pp.306-312, 2020 (SCI-Expanded, SSCI, Scopus)

4. Effects of atorvastatin on talinolol absorption: A potential drug-drug interaction

Kara Z. P., Ozturk D., ÖZTÜRK N., Orman M., BAKTIR G., OKYAR A.

Pharmazie , vol.75, no.2-3, pp.70-74, 2020 (SCI-Expanded, Scopus)

5. Rational Drug Use Awareness in University Students Training Outside of Health Area and Health Area Sağlık Alanı ve Sağlık Alanı Dışında Eğitim Alan Üniversite Öğrencilerinde Akılcı İlaç Kullanımı Farkındalığı

ŞAHİN E., DAYIOĞLU N., Ökmen B., Korkmaz E., Baykara Ş., BAKTIR G.

Experimed , vol.9, no.1, pp.32-38, 2019 (Scopus)

6. Wound Repair and Experimental Wound Models Yara İyileşmesi ve Deneysel Yara Modelleri

BAKTIR G.

Experimed , vol.9, no.3, pp.130-137, 2019 (Scopus)

7. İlaçlar İle Teofilin, Teobromin, Kafein İçeren Besinler Arasındaki Etkileşimler.

Baktır G., Güler E. C.

Lectio Scientific Journal of Health and Natural Sciences , vol.2, no.2, pp.82-96, 2018 (Peer-Reviewed Journal)

8. Therapeutic Drug Monıtoring (TDM)

Baktır G.

Lectio Scientific Journal of Health and Natural Sciences , vol.1, no.1, pp.54-65, 2017 (Peer-Reviewed Journal)

9. Safety of Herbal Self- Medication in Diabetes

ŞAHİN E., İPLİK E. S., BAKTIR G., ÖZHATAY E.

Turkish Journal of Molecular Biology and Biotechnology , vol.2, no.1, pp.62, 2017 (Peer-Reviewed Journal)

10. Circadian variations in exsorptive transport: In situ intestinal perfusion data and in vivo relevance

OKYAR A., Dressler C., Hanafy A., BAKTIR G., Lemmer B., Spahn-Langguth H.

Chronobiology International , vol.29, no.4, pp.443-453, 2012 (SCI-Expanded, Scopus)

11. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: An alternative approach to oral and parenteral routes

GÜNGÖR S., OKYAR A., Erturk-Toker S., BAKTIR G., Ozsoy Y.

Drug Development and Industrial Pharmacy , vol.36, no.7, pp.806-813, 2010 (SCI-Expanded, Scopus)

12. Ondansetron-loaded biodegradable microspheres as a nasal sustained delivery system: In vitro/in vivo studies

GÜNGÖR S., OKYAR A., Erturk-Toker S., BAKTIR G., Ozsoy Y.

Pharmaceutical Development and Technology , vol.15, no.3, pp.258-265, 2010 (SCI-Expanded, Scopus)

13. Nasal administration of ciprofloxacin HCL loaded chitosan microspheres: In vitro and in vivo evaluation Siprofloksazin HCl yüklü kitozan mikrokürelerinin nazal verilişi: In vitro ve in vivo deǧerlendirme

Gürcan D., OKYAR A., Özbek B., BAKTIR G., Gerçeker A., Özsoy Y.

Acta Pharmaceutica Sciencia , vol.52, no.1, pp.5-18, 2010 (Scopus)

14. Effect of terpenes as penetration enhancers on percutaneous penetration of tiaprofenic acid through pig skin

Okyar A., Yıldız Peköz A., Aksu B., Çınar Ç., Özsoy Y., Baktır G.

Acta Pharmaceutica Sciencia , vol.50, no.3, pp.247-256, 2008 (Scopus)

15. The effects of cetirizine on psychomotor performance in healthy volunteers

OKYAR A., BAKTIR G.

Journal of Pharmacy of Istanbul University , vol.38, no.1, pp.103-108, 2005 (Scopus)

16. Nasal administration of heparin-loaded microspheres based on poly(lactic acid)

YILDIZ PEKÖZ A., OKYAR A., BAKTIR G., Araman A., Özsoy Y.

Farmaco , vol.60, no.11-12, pp.919-924, 2005 (Scopus)

17. A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection

TOKER S., Çetin S. M., Atmaca S., Ersoy L., BAKTIR G.

Therapeutic Drug Monitoring , vol.27, no.1, pp.38-43, 2005 (SCI-Expanded, Scopus)

18. Pharmacokinetics and Tissue Levels of Tilmicosin in Fowls Tavuklarda Tilmikosinin Farmakokinetiǧi ve Dokulardaki Düzeyleri

Keleş O., BAKIREL T., Şener S., BAKTIR G., Daǧoǧlu G., Özkan O.

Turkish Journal of Veterinary and Animal Sciences , vol.25, no.4, pp.629-634, 2001 (SCI-Expanded, Scopus, TRDizin)

19. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models

OKYAR A., ARSLAN A., Akev N., BAKTIR G., Sütlüpinar N.

Phytotherapy Research , vol.15, no.2, pp.157-161, 2001 (SCI-Expanded, Scopus)

20. Efficacy of 7-day treatment with metronidazole+miconazole (Neo-Penotran®) - A triple-active pessary for the treatment of single and mixed vaginal infections

Ozyurt E., Toykuliyeva M., Danilyans I., Morton O., BAKTIR G.

International Journal of Gynecology and Obstetrics , vol.74, no.1, pp.35-43, 2001 (SCI-Expanded, Scopus)

21. Gemfibrozil and its oxidative metabolites: Quantification of aglycones, acyl glucuronides, and covalent adducts in samples from preclinical and clinical kinetic studies

Hermening A., Gräfe A., BAKTIR G., Mutschler E., Spahn-Langguth H.

Journal of Chromatography B: Biomedical Sciences and Applications , vol.741, no.2, pp.129-144, 2000 (Scopus)

22. P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound

Spahn-Langguth H., BAKTIR G., Radschuweit A., OKYAR A., Terhaag B., Ader P., et al.

International Journal of Clinical Pharmacology and Therapeutics , vol.36, no.1, pp.16-24, 1998 (SCI-Expanded, Scopus)

23. Synthesis of new 2-arylidene-2H-1,4-benzoxazin-3(4H)-ones

Gezginci H., Salman S., OKYAR A., BAKTIR G.

Farmaco , vol.52, no.4, pp.255-256, 1997 (SCI-Expanded, Scopus)

24. The interaction of glipizide with trimethoprim-sulfamethoxazole and trimethoprim-sulfadiazine

Ekinci A., BAKTIR G., ÖZER H., Sunam G., ÖZDEMİR Ö.

Acta Pharmaceutica Turcica , vol.36, no.4, pp.92-95, 1994 (Scopus)

25. Cumulative urinary excretion of some ciprofloxacin tablets in healthy volunteers

Ekinci A., BAKTIR G., Otuk G., ÖZDEMİR Ö., Sunam G., ÖZER H.

Scientia Pharmaceutica , vol.62, no.3, pp.247-253, 1994 (Scopus)

26. P185 computer-assisted videomicroscopy: Effects of some antihypertensives on guinea-pig ileum resistance vessels

BAKTIR G., Bungardt E., Mutschler E.

European Journal of Pharmaceutical Sciences , vol.2, no.1-2, pp.165, 1994 (Scopus)

27. Effect of food and water volume on the oral bioavailability of erythromycin stearate tablets

BAKTIR G., Gerceker A., Otuk G., Sunam G.

Acta Pharmaceutica Turcica , vol.36, no.1, pp.25-30, 1994 (Scopus)

28. The Effect of Cyproheptadine and Amantadine on Neuroleptic-Induced Catalepsy in the Rat

Ekinci A. C., Baktır G., Sunam G., Özdemir O.

J. Fac. Pharm. Istanbul , vol.29, no.1, pp.59-64, 1993 (Peer-Reviewed Journal)

29. Effects of buspirone and placebo on psychomotor performance in healthy volunteers

BAKTIR G., Uzbay I., Atay H., Sunam G.

Acta Pharmaceutica Turcica , vol.34, no.1, pp.27-32, 1992 (Scopus)

30. Cumulative urinary excretion of some ampicillin preparations as a parameter of relative bioavailibility

Atay h. h., BAKTIR G., ÖZDEMİR Ö.

Scientia Pharmaceutica , vol.59, no.3, pp.233-238, 1991 (Scopus)

31. Quinazolinones. 19. Communication [1]: Synthesis and evaluation of some CNS depressant properties of 3-{2-[(5-aryl-1,3,4-oxadiazole-2-yl)amino]acetamido}-2-methyl-4(3H)- quinazolinones

Ergenc N., Buyuktimkin S., Capan G., BAKTIR G., Rollas S.

Pharmazie , vol.46, no.4, pp.290-291, 1991 (Scopus)

32. Cumulative urinary excretion and saliva levels of ciprofloxacin in healthy volunteers

BAKTIR G., Otuk G., Ekinci A., ÖZDEMİR Ö., Sunam G.

Acta Pharmaceutica Turcica , vol.32, no.4, pp.163-167, 1990 (Scopus)

33. Excessive motor impairment two hours after Triazolam in the elderly

Fisch H., BAKTIR G., Karlaganis G., Minder C., Bircher J.

European Journal of Clinical Pharmacology , vol.38, no.3, pp.229-232, 1990 (Scopus)

34. The Effect of Atenolol on Glibornuride Induced Hypoglycemia.

Özdemir O., Baktır G., Ekinci A. C., Sunam G.

Acta Pharmaceutica Turcica , vol.30, pp.25-27, 1988 (Peer-Reviewed Journal)

35. The Effect of Diphenylhydantoin on the Cataleptogenic Effects of Thioridazine and Pimozide.

Ekinci A. C., Özdemir O., Baktır G., Sunam G.

Acta Pharmaceutica Turcica , vol.30, pp.33-36, 1988 (Peer-Reviewed Journal)

36. Mechanism of the Excessive Sedative Response of Cirrhotics to Benzodiazepines: Model Experiments with Triazolam

Baktır G., Fisch H. U., Karlaga G., Mınder ., Bırcher J.

HEPATOLOGY , vol.7, no.4, pp.629-638, 1987 (Scopus)

37. A Comparison of the Relative Bioavailability of two Acetaminophen Tablets Marketed in Turkey

Baktır G., Sunam G.

Acta Pharmaceutica Turcica , vol.28, pp.19-24, 1986 (Peer-Reviewed Journal)

38. In Vitro Adsorption of Hyoscine-N-Butyl Bromide by Different Antacids.

Özdemir O., Baktır G., Ekinci A. C.

Acta Pharmaceutica Turcica , vol.28, pp.83-86, 1986 (Peer-Reviewed Journal)

39. Excessive effects of benzodiazepines in patients with cirrhosis of the liver: A pharmacodynamic or a pharmacokinetic problem?

Fisch H., BAKTIR G., Karlagenis G., Bircher J.

Pharmacopsychiatry , vol.19, no.1, pp.14, 1986 (Scopus)

40. Capillary Gas-Liquid Chromatographic Determination of the Benzodiazepine Triazolam in Plasma Using a Retention Gap

Baktır G., Bircher J., Fisch H. U., Karlaganis G.

JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES , vol.339, pp.192-197, 1985 (Peer-Reviewed Journal)

41. Capillary gas-liquid chromatographic determination of the benzodiazepine triazolam in plasma using a retention gap

BAKTIR G., Bircher J., Fisch H., Karlaganis G.

Journal of Chromatography B: Biomedical Sciences and Applications , vol.339, no.C, pp.192-197, 1985 (Scopus)

42. The Effect of Clonazepam on the Blood Glucose and Cholesterol Levels of Rats

Sunam G., Baktır G., Özdemir O., Ekinci A. C.

Eczacılık Bülteni , vol.25, pp.34-37, 1983 (Peer-Reviewed Journal)

43. Triazolam concentration-effect relationships in healthy subjects

BAKTIR G., Fisch H., Huguenin P., Bircher J.

Clinical Pharmacology and Therapeutics , vol.34, no.2, pp.195-201, 1983 (Scopus)

44. Treatment of sleep disorders THERAPIE VON SCHLAFSTORUNGEN

Fisch H., Baktır G., Bircher J.

Therapeutische Umschau , vol.39, no.11, pp.868-874, 1982 (Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 63

1. Türkiye’de Farmakovijilans ve Kalite Açısından İlaçta Geri Çekmelerin Değerlendirilmesi: Valsartan Örneği

ŞAHİN E., BİÇER S., BAKTIR G.

25. ULUSAL FARMAKOLOJİ KONGRESİ, 04 November 2019, (Full Text)

2. Sağlık Tesislerinde Sitotoksik İlaçlarda Güvenlik Uygulamaları

Baktır G.

Uluslararası Bütünleşik Sağlık ve Bakım Kongresi, İstanbul, Turkey, 29 November - 02 December 2017, (Unpublished)

3. Üniversite Öğrencilerinin Akılcı İlaç Kullanımı Farkındalığının Değerlendirilmesi

ŞAHİN E., Korkmaz E., Ökmen B., Baykara Ş., BAKTIR G.

24. Ulusal Farmakoloji Kongresi, Turkey, 17 - 21 October 2017, pp.158, (Summary Text)

4. Safety of Herbal Self- Medication in Diabetes

ŞAHİN E., İPLİK E. S., BAKTIR G., ÖZHATAY E.

II. International Cogress of Moleculer Medicines, 22 - 25 May 2017, vol.2, pp.62, (Full Text)

5. Personalized Genomics-Personalized Surgery

Baktır G.

VI. International Congress of Molecular Medicine, İstanbul, Turkey, 25 - 27 May 2017, (Unpublished)

6. Hipertansiyon Tedavisinde, İzleminde ve Hasta Eğitiminde Eczacıların Rolü

Haksever M. A., ŞAHİN E., BAKTIR G.

3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Turkey, 9 - 12 February 2017, (Summary Text)

7. Nanotechnology in microbiology

TAN E., ÖZYARAL O., BAKTIR G.

13th International Multidisciplinary Scientific Geoconference and EXPO, SGEM 2013, Albena, Bulgaria, 16 - 22 June 2013, pp.57-66, (Full Text)

8. Nanotechnology applications of antimicrobials

TAN E., ÖZYARAL O., BAKTIR G.

13th International Multidisciplinary Scientific Geoconference and EXPO, SGEM 2013, Albena, Bulgaria, 16 - 22 June 2013, pp.45-55, (Full Text)

9. Hepatoprotective effect of Smilax excelsa L

Özsoy N., Okyar A., Can A., Akev N., Baktır G.

The 2nd International Symposium on Medicinal Plants, Their Cultivation and Aspects of Uses, Ma'an, Jordan, 1 - 04 November 2010, pp.36-37, (Full Text)

10. Effect of Smilax excelsa L. on the antioxidant system in kidney tissue.

Özsoy N., Okyar A., Akev N., Can A., Baktır G.

The 2nd International Symposium on Medicinal Plants, Their Cultivation and Aspects of Uses, Ma'an, Jordan, 1 - 04 November 2010, pp.37-38, (Full Text)

11. Effect of Smilax excelsa L. leaf extract on liver injury in rats

Özsoy N., Arda B. P., Okyar A., Bolkent Ş., Akev N., Baktır G.

The 17th IFSM International Microscopy Congress , Rio De Janeiro, Brazil, 1 - 04 September 2010, pp.0-24, (Full Text)

12. Effect of terpens as penetration enhancers on percutaneous penetration of tiaprofenic acid through pig skin

Okyar A., Yıldız Peköz A., Aksu N. B., Erginer Y., Baktır G.

6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, Spain, 7 - 10 April 2008, pp.11-12, (Full Text)

13. Circadian changes in intestinal secretion: Drug-drug interactions with the P-glycoprotein (P-gp) substrate talinolol

Okyar A., Baktır G., Spahn-Langguth H.

49th Annual Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology, Mainz, Germany, 11 - 13 March 2008, vol.377, pp.62, (Summary Text)

14. Self-management of complications in diabetic patients: a pharmaceutical care program in community pharmacies.

Köroğlu A., Çakıroğlu A., Öztosun Z. A., Dündar A., Alp Yıldırım F. İ., Okyar A., et al.

36th European Symposium on Clinical Pharmacy, Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience, İstanbul, Turkey, 25 - 27 October 2007, pp.11, (Summary Text)

15. Pre-diabetes screening program: A proactive study in Istanbul Community Pharmacies

Çakıroğlu A., Köroğlu A., Öztosun Z. A., Dündar A., Okyar A., Alp Yıldırım F. İ., et al.

36th European Symposium on Clinical Pharmacy, Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience, İstanbul, Turkey, 25 - 27 October 2007, pp.10, (Summary Text)

16. P-glikoprotein (P-gp) substratları arasındaki ilaç-ilaç etkileşmeleri: P-gp' ye bağımlı intestinal sekresyondaki gece-gündüz farklılığının talinololün farmakokinetiğine etkisi.

Okyar A., Baktır G., Spahn-Langguth H.

XIX. Ulusal Farmakoloji Kongresi, Trabzon, Turkey, 24 - 27 October 2007, pp.12, (Full Text)

17. in vitro and in vivo studies on ondansetron HCl loaded biodegradable mıcrospheres

Erginer Y., Güngör S., Okyar A., Toker S., Baktır G.

Pharmaceutical Sciences World Congress, Amsterdam, Netherlands, 22 - 25 April 2007, pp.1, (Summary Text)

18. Vücutta Parçalanabilen Heparin Mikrokürelerinin Nazal Yol ile Uygulanması

Erginer Y., Yıldız Peköz A., Okyar A., Baktır G., Araman A.

VI. Ulusal Tromboz, Hemostaz ve Anjiolojik Kongresi, İzmir, Turkey, 5 - 07 May 2006, pp.1, (Summary Text)

19. In vitro and In vivo Evaluation of Ciprofloxacin HCl Loaded Chitosan Microspheres by Spray-Drying Method and In Vivo Evaluation for Nasal Administration

Erginer Y., Gürcan D., Okyar A., Karakoç B., Baktır G., Gerçeker A.

European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain, 10 - 12 May 2004, pp.1, (Full Text)

20. Circadian variation in effective permeabilities of talinolol and losartan in rats: Metabolism- or transport- related?

Lemmer B., Dressler C., Okyar A., Baktır G., Spahn-Langguth H.

45th Spring Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology, Mainz, Germany, 9 - 11 March 2004, pp.369, (Summary Text)

21. Biodegradable heparin microspheres: II. Nasal administration of heparin microspheres

Yıldız Peköz A., Okyar A., Araman A., Baktır G., Erginer Y.

5th International Conference and Workshop on Cell Culture and In-Vitro Models for Drug Absorption and Delivery, Saarbrücken, Germany, 25 February - 05 March 2004, pp.1, (Summary Text)

22. Absorption and tolerability of Neo-Penotran Forte and Neo-Penotran Forte-L pessaries in healthy volunteers

Baktır G., Huseyinova L., Toykuliyeva M., Özyurt E., Danilyans I.

World Conference on Vaginitis, Puntarenas, Costa Rica, 10 - 13 January 2004, pp.2, (Summary Text)

23. Efficacy of once daily, 7-day treatment with 750 mg metronidazole + 200 mg miconazole nitrate (Neo-Penotran  Forte) – a triple- active pessary for the treatment of single and mixed vaginal infections”

Huseyinova L., Baktır G., Özyurt E., Toykuliyeva M., Danilyans İ.

World Conference on Vaginitis, Puntarenas, Costa Rica, 10 - 13 January 2004, pp.1, (Summary Text)

24. P-glikoprotein inhibitörü atorvastatinin talinololün emilim ve dağılımına etkisi.

Baktır G., Okyar A., Pala Kara Z., Spahn-Langguth H.

XVII. Ulusal Farmakoloji Kongresi , Antalya, Turkey, 17 - 21 October 2003, pp.3, (Summary Text)

25. Simvastatinin talinolol farmakokinetiğine etkisi

Pala Kara Z., Baktır G., Okyar A.

XVII. Ulusal Farmakoloji Kongresi, Antalya, Turkey, 17 - 21 October 2003, pp.1, (Summary Text)

26. Talinolol ve losartanın efektif intestinal permeabilitesindeki sirkadiyen değişimler: Transporta mı –yoksa metabolizmaya mı- bağımlı?

Baktır G., Dressler C., Okyar A., Lemmer B., Spahn-Langguth H.

XVII. Ulusal Farmakoloji Kongresi , Antalya, Turkey, 17 - 21 October 2003, pp.2, (Summary Text)

27. Efficacy of once daily, 7 day treatment with Neo-Penotran Forte - a triple active pessary for the treatment of single and mixed vaginal infections

Hüseyinova L., Toykuliyeva M., Özyurt E., Danilyans I., Baktır G.

10th International Congress of Infectious Diseases, Singapore, Singapore, 5 - 10 June 2002, (Summary Text)

28. Tolerance, Acceptability and Absorption study of Neo-Penotran Forte-L and Neo-Penotran Forte Pessaries in Healthy Volunteers

Hüseyinova L., Toykuliyeva M., Özyurt E., Danilyans İ., Baktır G.

10th International Congress Of Infectious Diseases, Singapore, Singapore, 5 - 10 June 2002, (Summary Text)

29. Comparison of the in vitro diffusion of nimesulide from commercially available gel formulations.

Senorkyan L., Kara D., Embil K., Baktır G.

8th international Conference 'Perspectives in Percutaneous Penetrarion, Paris, France, 2 - 06 April 2002, pp.88, (Summary Text)

30. P-glikoprotein substratları arasındaki ilaç etkileşmeleri: i.v. ve p.o. yoldan uygulanan vinblastinin talinololün emilimine ve dağılımına etkisi.

Okyar A., Hanafy A., Baktır G., Spahn-Langguth H.

XVI. Ulusal Farmakoloji Kongresi, Aydın, Turkey, 1 - 05 October 2001, pp.1, (Summary Text)

31. Drug-drug interactions with P-glycoprotein substrates: Mechanism for AUC increase is different for p.o. and i.v. vinblastine coadministration?

Okyar A., Hanafy A., Baktır G., Spahn-Langguth H.

Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, 42. Spring Meeting, Mainz, Germany, 1 - 04 March 2001, pp.0-115, (Full Text)

32. Efficacy of 7-day treatment with Metronidazole+Miconazole (Neo-Penotran) - A triple active pessary for the treatment of vaginitis

Toykuliyeva M., Danilyans İ., Allakova O., Tagiyeva Y., Kadamov G., Özyurt E., et al.

9th International Congress of Infectious Diseases, Buenos Aires, Argentina, 10 - 13 April 2000, (Summary Text)

33. Covalent Binding of Gemfibrozil and its Oxidative Metabolites in Rat Tissues upon Repetitive Dosing

Hermening A., Baktır G., Mutschler E., Spahn Langguth H.

Deutsche Pharmakologische Gesellschaft, Doktorandentagung, , Frankfurt, Germany, 1 - 02 February 2000, (Unpublished)

34. Terfenadinin genç deneklerde psikomotor performansa etkisi

Hocaoğlu N., Okyar A., Baktır G.

XV. Ulusal Farmakoloji Kongresi, Antalya, Turkey, 1 - 05 November 1999, pp.12-13, (Summary Text)

35. Aloe vera yapraklarının tip-I ve tip-II diabetik sıçanların kan glukoz düzeyine etkisi

Okyar A., Baktır G.

XV. Ulusal Farmakoloji Kongresi , Antalya, Turkey, 1 - 05 November 1999, pp.4-7, (Full Text)

36. Effects of Aloe Vera Leaves on Blood Glucose Level in Type - I and Type - II Diabetic Rat Models

Okyar A., Can A., Akev N., Baktır G., Sütlüpınar N.

2000 Years of Natural Products Research; Past, Present and Future, Amsterdam, Netherlands, 26 - 30 July 1999, pp.1, (Summary Text)

37. Setirizinin psikomotor performansa etkisinin psikometrik testlerle incelenmesi.

Okyar A., Baktır G.

XIV. Ulusal Farmakoloji Kongresi, Antalya, Turkey, 2 - 07 November 1997, pp.772-777, (Full Text)

38. P- glikoproteine bağımlı transportun verapamil tarafından inhibisyonu: Talinololün sıçandaki farmakokinetiğine etkisi.

Baktır G., Okyar A., Ader P., Radschuweit A., Terhaag B., Spahn-Langguth H., et al.

XIV. Ulusal Farmakoloji Kongresi, Antalya, Turkey, 2 - 07 November 1997, pp.63, (Summary Text)

39. Inhibition of P-Glycoprotein-Dependent transport Processes by Verapamil: Influence on the Pharmacokinetics of Talinolol in the Rat.

Langguth P., Ader P., Baktır G., Okyar A., Radschuweit A., Terhaag B., et al.

The Impact of Pharmacokinetics in Modern Drug Development (Symposium), California, United States Of America, 16 - 17 May 1997, pp.1, (Summary Text)

40. Hemmung P-Glykoprotein- abhangiger Transportprozesse durch Verapamil: Beeinflussung der Kinetik von Talinolol bei der Ratte

Ader P., Baktır G., Radschuweit A., Terhaag B., Langguth P., Spahn-Langguth H.

9. Frühjahrstagung der Deutschen Pharmazeutischen Gesellschaft für den wissenschaftlichen Nachwuchs, Würzburg, Germany, 13 - 16 March 1997, (Summary Text)

41. Vasodilator properties of several antihypertensives in guinea-pig ileum resistance vessels.

Bungardt E., Baktır G., Mutschler E.

Naunyn-Schmiedeberg’s Arch. Pharmacol. 351 (Suppl), Berlin, Germany, 1 - 02 January 1995, vol.351, pp.117, (Summary Text)

42. Computer - Assisted Videomicroscopy: Effects of Some Antihypertersives on Guinea-Pig Resistance Vessels.

Baktır G., Bungardt E., Mutschler E.

2nd European Congress of Pharmaceutical Sciences, Berlin, Germany, 29 September - 01 October 1994, pp.185, (Summary Text)

43. Eritromisin Stearat Tabletlerinden Biyoyararlanıma Besinlerin ve Sıvı Miktarının Etkisi.

Gerçeker A., Baktır G., Ötük G., Sunam G.

XI. Ulusal Farmakoloji Kongresi, Nevşehir, Turkey, 4 - 08 November 1992, pp.76, (Summary Text)

44. In vivo - In vitro Correlation of Prolonged Release Metformin HCl Tablets Prepared with Coating Materials.

Araman A. O., Erginer Y., Baktır G.

1st European Congress of Pharmaceutical Sciences, Amsterdam, Netherlands, 7 - 09 October 1992, pp.31, (Summary Text)

45. The Effect of Hydroxyzine on Psychomotor Performance in Healthy Young Volunteers.

Baktır G., Atay H., Ekinci A. C., Özdemir O., Sunam G.

18th Collegium Internationale Neuro- Psychopharmacologicum Congress, Nice, France, 28 June - 02 July 1992, pp.72, (Summary Text)

46. The Effect of a Single Oral Dose of Doxylamine on Psychomotor Performance in Healthy Young Volunteers.

Baktır G., Özdemir O., Ekinci A. C., Sunam G.

18th Collegium Internationale Neuro-Psychopharmacologicum Congress, Nice, France, 28 June - 02 July 1992, pp.73, (Summary Text)

47. The Interaction of Glipizide with Trimethoprim / Sulphamethoxazole.

Ekinci A., Baktır G., Özdemir O., Sunam G., Özer H.

Pharmacy World Congress 1991, Washington, United States Of America, 1 - 06 September 1991, pp.17, (Summary Text)

48. Cumulative Urinary Excretion and Saliva Levels of Ciprofloxacin in Healthy Subjects

Baktır G., Ötük G., Ekinci A., Özdemir O., Sunam G.

Pharmacy World Congress 1991, Washington, United States Of America, 1 - 06 September 1991, pp.10, (Summary Text)

49. Excessive Effects of Benzodiazepines in Liver Disease and in the Aged: Model Experiments with Triazolam.

Fisch H. U., Baktır G., Karlaganis G., Minder C., Bircher J.

The Third Tokyo Symposium - Liver and Aging-1986, Tokyo, Japan, 20 - 22 August 1986, pp.23, (Summary Text)

50. Do Patients with cirrhosis of the liver and healthy elderly subjects realize their excessive sedation under benzodiazepines ?

Baktır G., Fisch H., Karlaganis G., Minder C., Bircher J.

3rd Tokio Symposium on Liver and Aging, Tokyo, Japan, 20 - 22 August 1986, pp.309-320, (Full Text)

51. Psychomotor Performance, an Indicator of Ingreased Sensitivity of the Brain to Benzodiazepines in Healthy Elderly Subjects.

Fisch H., Baktır G., Karlaganis G., Minder C., Bircher J.

XIIIth International Congress of Gerontology, New York, United States Of America, 12 - 17 July 1985, pp.177, (Summary Text)

52. Exzessive Wirkungen von Benzodiazepinen bei Zirrhotikern

Fisch H., Baktır G., Karlaganis G., Bircher J.

Deutsche Gesellschaft für Klinische Chemie - Merck Symposium, Göttingen, Germany, 16 - 18 May 1985, pp.180-182, (Full Text)

53. Excessive Effects of Benzodiazepines in Patients with Cirrhosis of the Liver: A Pharmacodynamic or a Pharmacokinetic Problem ?

Fisch H. U., Baktır G., Karlaganis G., Bircher J.

Joint Meeting of the European College of Neuropsychopharmacology, Kobenhavn, Denmark, 2 - 03 May 1985, pp.14, (Summary Text)

54. Eine periphere visuelle Funktion zur Erfassung der Überempfindlichkeit von Benzodiazepinen bei Patienten mit Leberzirrhose

Fisch H., Baktır G., Karlaganis G., Bircher J.

5th International Meeting of Pharmaceutical Physicians, Munich, Germany, 14 - 17 October 1984, pp.12, (Summary Text)

55. Mechanisms for Disproportionate Sedation after Benzodiazepines in Cirrhosis: Model Experiments with Triazolam

Baktır G., Fisch H. U., Karlaganis G., Bircher J.

IASL, International Association for the Study of the Liver, Bern, Switzerland, 3 - 04 September 1984, pp.6, (Summary Text)

56. A Visual Perceptive Function as Quantitative Indicator for Benzodiazepine Effects in Cirrhosis

Baktır G., Fisch H. U., Karlaganis G., Bircher J.

IUPHAR 9th International Congress of Pharmacology, London, England, 29 July - 03 August 1984, pp.638, (Summary Text)

57. Pharmacokinetic Consequences of Liver Disease for the Elimination of Triazolam

Baktır G., Karlaganis G., Fisch H. U., Bircher J.

Ninth European Workshop on Drug Metabolism, Nancy, France, 11 - 15 June 1984, pp.157, (Summary Text)

58. Effect of Triazolam on Flicker Sensitivity at Different Frequencies

Fisch H. U., Wyler A., Baktır G., Karlaganis G., Bircher J.

16 th Annual Meeting of the Union of the Swiss Societies for Experimental Biology (USGEB / USS-BE), Zürich, Switzerland, 29 - 30 March 1984, pp.644-645, (Summary Text)

59. Impaired Elimination of Triazolam in Patients with Cirrhosis of the Liver

Baktır G., Karlaganis G., Fisch H. U., Bircher J.

16th Annual Meeting of the Union of the Swiss Societies for Experimental Biology (USGEB/USS-BE), Zürich, Switzerland, 29 - 30 March 1984, pp.643, (Summary Text)

60. Differential Explanation for Excessive and Prolonged Sedation Due to Triazolam in Cirrhosis

Baktır G., Fisch H. U., Karlaganis G., Bircher J.

Deutsche Pharmakologische Gesellschaft, The 25th Spring Meeting, Mainz, Germany, 13 - 16 March 1984, pp.361, (Summary Text)

61. Quantitative Assessment of the Hypersensitivity of the Brain to Benzodiazepines in Cirrhosis

Baktır G., Fisch H. U., Bircher J.

Fifth International Gstaad Symposium; “The Liver: Handling of Endo- and Xenobiotics” , Bern, Switzerland, 12 - 14 September 1983, pp.31, (Summary Text)

62. Triazolam Concentration - Effect Relationship

Baktır G., Fisch H. U., Huguenin P., Bircher J.

VIIth World Congress of Psychiatry, Vienna, Austria, 11 - 16 July 1983, pp.475, (Summary Text)

63. Triazolam Concentration - Effect Relationship in Healthy Volunteers

Baktır G., Bircher J., Huguenin P., Karlaganis G.

15th Annual Meeting of the Union of the Swiss Societies for Experimental Biology (USGEB/USS-BE), Fribourg, Switzerland, 17 - 18 March 1983, pp.15, (Summary Text)

Books 12

Metrics

Publication

119

Publication (WoS)

Publication (Scopus)

Citation (WoS)

120

Citation (Scopus)

640

H-Index (Scopus)

Citation (Scholar)

257

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Intellectual Property

Thesis Advisory

Open Access